StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Ackman's Pershing Square Said Down $666M+ This Week on Valeant Pharma (VRX) Stake
March 15, 2016 11:28 AM
As Valeant Pharma (NYSE: VRX) continues lower, one investor is feeling some major ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Hedge Funds
Trader Talk
Next Articles
Ackman Said to Add to Valeant Pharma (VRX) Stake - Chatter
March 15, 2016 3:58 PM
UPDATE: Piper Jaffray Downgrades Valeant Pharmaceuticals (VRX) to Underweight
March 15, 2016 11:15 AM
Valeant Pharma (VRX) Results Suggest Disruption in the Business - Evecore ISI's Raffat
March 15, 2016 10:56 AM